Position in GRFS
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$1,947,953
-$511,863 QoQ
Shares Held
242,887
-7.7% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026State of Wyoming holds $5,733,697 across 12 Drug Manufacturers - General names. GRFS ranks #1 (34.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GRFS |
Grifols SA
This page
|
242,887 | $1,947,953 | |
| 2 | LLY |
ELI LILLY & Co
|
1,411 | $1,297,795 | |
| 3 | JNJ |
Johnson & Johnson
|
4,275 | $1,044,981 | |
| 4 | OGN |
Organon & Co.
|
54,310 | $325,316 | |
| 5 | MRK |
Merck & Co., Inc.
|
2,188 | $263,194 | |
| 6 | BIIB |
Biogen Inc.
|
1,296 | $237,595 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
3,365 | $204,087 | |
| 8 | NVS |
Novartis AG
|
942 | $143,890 |
All Filings in GRFS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,947,953 | 242,887 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,459,816 | 263,082 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $2,346,426 | 235,585 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $1,728,529 | 191,209 | Shares | Sole | 2025-08-19 | |
| No filing history on record for this holder in this stock. | ||||||